About the Authors
- Shinji Shimato
-
Affiliation Department of Neurosurgery, Gabriele Bartoli Brain Tumor Research Laboratory, Columbia University, New York, New York, United States of America
- Lisa M. Anderson
-
Affiliation Erinyes Biotechnologies, LLC, Boston, Massachusetts, United States of America
- Martin Asslaber
-
Affiliation Department of Pathology, Medical University of Graz, Graz, Austria
- Jeffrey N. Bruce
-
Affiliation Department of Neurosurgery, Gabriele Bartoli Brain Tumor Research Laboratory, Columbia University, New York, New York, United States of America
- Peter Canoll
-
Affiliations Department of Neurosurgery, Gabriele Bartoli Brain Tumor Research Laboratory, Columbia University, New York, New York, United States of America, Department of Pathology, Columbia University, New York, New York, United States of America
- David E. Anderson
-
Affiliation Erinyes Biotechnologies, LLC, Boston, Massachusetts, United States of America
- Richard C. E. Anderson
-
* E-mail: rca24@columbia.edu
Affiliation Department of Neurosurgery, Gabriele Bartoli Brain Tumor Research Laboratory, Columbia University, New York, New York, United States of America
Competing Interests
Two of the authors of this manuscript (LMA and DEA) are managers of Erinyes Biotechnologies, LLC. A patent was filed on 6/19/13 by Columbia University titled “Caveolin-1 inhibits myeloid cells in glioblastoma” (Application serial number 61/837,164). This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: SS LMA DEA RCA. Performed the experiments: SS LMA DEA MA. Analyzed the data: SS LMA DEA MA RCA. Contributed reagents/materials/analysis tools: JB PC MA. Wrote the manuscript: SS LMA DEA MA PC JB RCA.